| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |